
Last month, Tavistock and Portman NHS Trust which runs the UK’s largest gender identity development service for children, was granted permission to appeal the ruling in which judges found that children under 16 are unlikely to be able to give informed consent to undergo treatment with puberty-blocking drugs.
The case was brought by Kiera Bell, a 23-year-old woman who was referred to the Tavistock Centre as a teenager and was prescribed puberty blockers aged 16.
She argued the clinic should have challenged her more over her decision to transition to a male as a teenager.
Register Now to Continue Reading
Thank you for visiting Children & Young People Now and making use of our archive of more than 60,000 expert features, topics hubs, case studies and policy updates. Why not register today and enjoy the following great benefits:
What's Included
-
Free access to 4 subscriber-only articles per month
-
Email newsletter providing advice and guidance across the sector
Already have an account? Sign in here